Price
Financials
Consolidated, Rs crore| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 58.74 | 104.32 | 134.86 | 68.01 | 121.48 | 62.76 | 158.52 | 74.98 |
| Expenses | 54.15 | 81.45 | 116.50 | 74.22 | 91.02 | 74.36 | 136.31 | 70.74 |
| Operating Profit | 4.59 | 22.87 | 18.36 | -6.21 | 30.46 | -11.60 | 22.21 | 4.24 |
| OPM % | 7.81% | 21.92% | 13.61% | -9.13% | 25.07% | -18.48% | 14.01% | 5.65% |
| Other Income | 2.36 | 1.75 | 3.29 | 2.75 | 3.18 | 7.10 | 9.85 | 3.15 |
| Interest | 0.24 | 0.43 | 1.09 | 1.34 | 1.07 | 0.87 | 0.88 | 0.86 |
| Depreciation | 0.70 | 0.69 | 0.63 | 1.39 | 1.31 | 1.31 | 1.29 | 1.30 |
| Profit before tax | 6.01 | 23.50 | 19.93 | -6.19 | 31.26 | -6.68 | 29.89 | 5.23 |
| Tax % | 14.81% | 12.98% | 24.23% | -1.13% | 10.08% | -15.12% | 26.23% | 19.69% |
| Net Profit | 5.12 | 20.46 | 15.09 | -6.13 | 28.11 | -5.68 | 22.06 | 4.21 |
| EPS in Rs | 1.58 | 6.32 | 4.66 | -1.89 | 8.68 | -1.28 | 4.96 | 0.95 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 133 | 121 | 257 | 194 | 226 | 327 | 411 | 418 |
| Expenses | 119 | 110 | 225 | 169 | 191 | 288 | 376 | 372 |
| Operating Profit | 14 | 11 | 32 | 25 | 35 | 39 | 35 | 45 |
| OPM % | 11% | 9% | 12% | 13% | 15% | 12% | 9% | 11% |
| Other Income | 5 | 2 | 4 | 10 | 6 | 27 | 23 | 23 |
| Interest | 2 | 2 | 3 | 5 | 3 | 3 | 4 | 4 |
| Depreciation | 0 | 0 | 2 | 2 | 2 | 3 | 5 | 5 |
| Profit before tax | 16 | 11 | 31 | 28 | 36 | 60 | 48 | 60 |
| Tax % | 27% | 29% | 25% | 22% | 24% | 23% | 21% | |
| Net Profit | 12 | 8 | 23 | 22 | 27 | 46 | 38 | 49 |
| EPS in Rs | 12,390.00 | 8,040.00 | 84.28 | 78.00 | 92.44 | 14.34 | 8.63 | 13.31 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 7% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 28% | 28% | 14% | ||
| Compounded Profit Growth | % | 36% | 19% | 48% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | 20% | 17% | 12% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 3 | 3 | 3 | 32 | 44 |
| Reserves | 38 | 46 | 65 | 86 | 129 | 141 | 375 |
| Borrowings | 1 | 9 | 21 | 35 | 13 | 84 | 70 |
| Other Liabilities | 84 | 70 | 83 | 89 | 125 | 170 | 164 |
| Total Liabilities | 123 | 126 | 172 | 214 | 269 | 427 | 654 |
| Fixed Assets | 2 | 2 | 5 | 4 | 22 | 94 | 78 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 12 | 7 | 17 | 20 | 21 | 15 | 26 |
| Other Assets | 109 | 116 | 150 | 190 | 226 | 318 | 550 |
| Total Assets | 123 | 126 | 172 | 214 | 269 | 427 | 654 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 64 | -9 | -3 | -14 | 60 | -36 | 0 |
| Cash from Investing Activity | -28 | 4 | -9 | 2 | -30 | -20 | -112 |
| Cash from Financing Activity | -23 | 6 | 8 | 12 | -12 | 36 | 190 |
| Net Cash Flow | 13 | 1 | -4 | -0 | 18 | -20 | 78 |
| Free Cash Flow | 64 | -9 | -4 | -14 | 59 | -61 | 5 |
| CFO/OP | 417% | -65% | 4% | -15% | 196% | -68% | 36% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 110 | 135 | 120 | 187 | 156 | 168 | 182 |
| Inventory Days | 22 | 39 | 17 | 69 | 88 | 119 | 32 |
| Days Payable | 82 | 150 | 136 | 215 | 195 | 198 | 159 |
| Cash Conversion Cycle | 51 | 25 | 1 | 41 | 49 | 89 | 55 |
| Working Capital Days | -19 | 15 | 30 | 65 | 63 | 53 | 90 |
| ROCE % | 26% | 48% | 31% | 28% | 22% | 14% |
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Promoters | 68.94% | 68.94% | 68.94% |
| FIIs | 0.03% | 0.08% | 0.02% |
| DIIs | 1.99% | 2.15% | 2.45% |
| Public | 29.04% | 28.83% | 28.57% |
| No. of Shareholders | 31,755 | 28,620 | 29,408 |
Fundamentals
Market Cap₹ 661 Cr.
Current Price₹ 147
Stock P/E13.6
Book Value₹ 94.4
ROCE13.6 %
ROE12.5 %
Dividend Yield0.41 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)14%
Compounded Profit Growth (TTM)48%
Consolidated figures.
Valuation
Market capRs 637 Cr
Enterprise valueRs 648 Cr
P/E (TTM)20.29x
Price to book7.16x
Price to sales1.65x
EV / EBITDA13.70x
EV / EBIT15.19x
EV / sales1.68x
Earnings yield4.93%
Profitability
Operating margin (excl. other income)12.96%
Operating margin (incl. other income)17.99%
EBITDA margin12.23%
Pre-tax margin9.90%
Net profit margin8.11%
Net margin, latest quarter-9.05%
ROE27.80%
ROCE30.97%
ROA11.27%
ROE, 3-year average29.36%
ROCE, 3-year average35.08%
ROA, 3-year average11.18%
ROIC (approx.)33.08%
Tax rate22.08%
Other income / net worth10.96%
Growth
Sales growth (latest year)-24.64%
Profit growth (latest year)-7.45%
Sales CAGR, 3 years13.25%
Profit CAGR, 3 years20.59%
Sales growth QoQ-48.34%
Profit growth QoQ-120.21%
Sales growth YoY (latest quarter)-39.84%
Profit growth YoY (latest quarter)-127.76%
Per share
EPS (TTM)Rs 7.00
EPS (latest year)Rs 78.00
EPS (latest quarter)Rs -1.27
EPS, 3-year averageRs 2,734.09
Book value per shareRs 19.84
Sales per shareRs 86.33
Cash flow per shareRs -3.10
Free cash flow per shareRs 1.11
Efficiency
Asset turnover0.91x
Fixed asset turnover53.39x
Inventory turnover6.38x
Inventory days57 days
Debtor days187 days
Debtors turnover1.95x
Creditor days159 days
Cash conversion cycle55 days
Working capital days90 days
Leverage
Total debtRs 35 Cr
Cash and bankRs 24 Cr
Net debtRs 12 Cr
Debt to equity0.40x
Net debt / EBITDA0.25x
Interest coverage9.77x
Current ratio (filing 2026-03-31)2.50x
Quick ratio (filing 2026-03-31)2.39x
Trade payables (filing 2026-03-31)Rs 105 Cr
Owners' fund to total sources41.60%
Debt to assets16.58%
Cash flow
Cash from Operating Activity (latest year)Rs -14 Cr
Cash from Investing Activity (latest year)Rs 2 Cr
Cash from Financing Activity (latest year)Rs 12 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs 5 Cr
FCFE (approx.: FCF + change in debt)Rs 19 Cr
Cash from ops / profit, 5 years0.04x
Statement figures
Net sales (TTM)Rs 387 Cr
Net sales (latest year)Rs 194 Cr
Sales (latest quarter)Rs 63 Cr
Operating profit excl. other income (latest year)Rs 25 Cr
Operating profit (latest quarter)Rs -12 Cr
Other income (TTM)Rs 16 Cr
EBITDA (TTM)Rs 47 Cr
PBDT (TTM)Rs 43 Cr
Profit before tax (TTM)Rs 38 Cr
Tax (latest year)Rs 6 Cr
Net profit (TTM)Rs 31 Cr
Net profit (latest year)Rs 22 Cr
Net profit (latest quarter)Rs -6 Cr
Depreciation (TTM)Rs 5 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 4 Cr
Cost of goods sold (latest year)Rs 110 Cr
Total expenditure (latest year)Rs 169 Cr
Total income (latest year)Rs 204 Cr
Share capitalRs 3 Cr
ReservesRs 86 Cr
Shareholders' fundsRs 89 Cr
Total assetsRs 214 Cr
Net blockRs 4 Cr
InvestmentsRs 20 Cr
ReceivablesRs 99 Cr
InventoryRs 17 Cr
Other liabilitiesRs 89 Cr
Shares outstanding (crore)4.48
Ownership
Promoter holding68.94%
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | FABTECH | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -3.0% | -2.8% | -0.3 pts |
| 1 month | -3.8% | -6.8% | +3.0 pts |
| 3 months | -14.5% | -7.6% | -6.9 pts |
| 6 months | +2.1% | +0.4% | +1.6 pts |
1 mutual fund schemes hold about ₹0 Cr.
Over three months 1 bought more and 0 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| Bandhan BSE Healthcare Index Fund | 0.01% | 0 | +7% |
Red flags
F-score 3 of 8| explain | Weak cash conversion Cash from operations was -48% of net profit over the last 3 years |
| explain | High accruals Profit exceeded operating cash by 17% of total assets in 2026 |
| explain | Receivables outrunning sales Receivables grew 18% vs sales -25% in 2026 |
| explain | Debt up, profit down Borrowings up 68% while net profit fell in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹75 Cr +10.2% vs Jun 2025.
Net profit ₹4 Cr +168.7%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Syngene International Ltd | 14,823 | 50.0 | 9.99 % |
| Indegene Ltd | 14,580 | 35.0 | 18.8 % |
| Suven Life Sciences Ltd | 9,176 | -79.5 % | |
| Vimta Labs Ltd | 2,642 | 32.7 | 25.2 % |
| Bilcare Ltd | 229 | 11.5 | 7.06 % |
| Take Ltd | 208 | 35.2 | 18.5 % |
| Novelix Pharmaceuticals Ltd | 199 | 55.1 | 10.9 % |
| Jeevan Scientific Technology Ltd | 163 | 46.7 | 5.01 % |
| Adeshwar Meditex Ltd | 24 | 19.4 | 5.21 % |
| Vanta Bioscience Ltd | 15 | 133 | 1.19 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-08-17 | Dividend - Re 0.60 Per Share |
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Fabtech Technologies Ltd?
Fabtech Technologies Ltd (FABTECH) has a market capitalisation of Rs 661 Cr. at the 2026-10-01 close.
What is the P/E ratio of Fabtech Technologies Ltd?
Fabtech Technologies Ltd trades at a P/E of 13.6 on trailing twelve-month profit, at the 2026-10-01 close.
What were Fabtech Technologies Ltd's latest quarterly results?
In the Jun 2026 quarter, Fabtech Technologies Ltd sales was Rs 75 Cr (+10.2% vs Jun 2025) and net profit was Rs 4 Cr.
What is the 52-week high and low of Fabtech Technologies Ltd?
The 52-week high is Rs 262.80 and the 52-week low is Rs 132.70.